Filing Flows › Lucid Diagnostics (LUCD) › Q2 2026 › vs Q2 2025
Lucid Diagnostics (LUCD) Q2 2026 vs Q2 2025 (year over year)
Lucid Diagnostics's revenue rose $311K (+27%) from $1.2M in Q2 2025 to $1.5M in Q2 2026.
Lucid Diagnostics, Q2 2026: revenue $1.5M (+27% year over year), operating margin -868.5%, net loss $11.7M, operating cash flow −$11.3M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5M | $1.2M | $311K | +27% |
| Other income, net | $1.1M | $6.9M | −$5.8M | -84% |
| Net loss | $11.7M | $4.4M | $7.2M | +163% |
| Costs & expenses | $14.3M | $12.5M | $1.7M | +14% |
| Operating costs | $14.3M | $12.5M | $1.7M | +14% |
| Cost of revenue | $1.4M | $1.6M | −$118K | -8% |
| Research & development | $1.2M | $1.3M | −$63K | -5% |
| Sales & marketing | $5.8M | $4.0M | $1.8M | +44% |
| General & admin | $5.8M | $5.6M | $140K | +2% |
| Other operating costs | $105K | $105K | $0 | 0% |
| Operating cash sources | $13.2M | $11.9M | $1.3M | +11% |
| Depreciation & amortization | $224K | $222K | $2K | +0.9% |
| Share-based compensation | $1.7M | $1.1M | $551K | +48% |
| Cash used in operations | $11.3M | $10.5M | $748K | +7% |
| Net loss absorbed | $11.7M | $4.4M | $7.2M | +163% |
| Working capital & other | $1.5M | $7.5M | −$5.9M | -80% |
Questions
How much did Lucid Diagnostics's revenue grow year over year in Q2 2026?
Lucid Diagnostics's revenue rose $311K (+27%) from $1.2M in Q2 2025 to $1.5M in Q2 2026.